Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
23.00
Dollar change
+0.02
Percentage change
0.09
%
IndexRUT P/E- EPS (ttm)-2.32 Insider Own9.40% Shs Outstand42.24M Perf Week4.88%
Market Cap971.52M Forward P/E- EPS next Y-2.62 Insider Trans0.00% Shs Float38.27M Perf Month-3.97%
Income-97.22M PEG- EPS next Q-0.41 Inst Own33.45% Short Float30.73% Perf Quarter11.98%
Sales0.00M P/S- EPS this Y1.72% Inst Trans5.26% Short Ratio11.94 Perf Half Y5.99%
Book/sh3.25 P/B7.07 EPS next Y-14.91% ROA-50.31% Short Interest11.76M Perf Year-8.07%
Cash/sh2.87 P/C8.02 EPS next 5Y- ROE-53.27% 52W Range12.32 - 32.10 Perf YTD2.18%
Dividend Est.- P/FCF- EPS past 5Y-30.45% ROI-70.72% 52W High-28.35% Beta-0.42
Dividend TTM- Quick Ratio9.13 Sales past 5Y0.00% Gross Margin- 52W Low86.69% ATR (14)1.16
Dividend Ex-DateDec 13, 2012 Current Ratio9.13 EPS Y/Y TTM-22.28% Oper. Margin0.00% RSI (14)45.49 Volatility5.48% 4.69%
Employees29 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price75.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-5.65% Payout- Rel Volume0.39 Prev Close22.98
Sales Surprise- EPS Surprise3.85% Sales Q/Q- EarningsFeb 28 BMO Avg Volume984.72K Price23.00
SMA20-2.32% SMA50-5.55% SMA2005.10% Trades Volume379,573 Change0.09%
Date Action Analyst Rating Change Price Target Change
Nov-16-22Downgrade B. Riley Securities Buy → Neutral $44
Jul-15-21Downgrade Cantor Fitzgerald Overweight → Neutral $100
Jul-07-21Reiterated Maxim Group Buy $80 → $190
Apr-27-21Initiated B. Riley Securities Buy $78
Feb-16-21Reiterated H.C. Wainwright Buy $20 → $66
Oct-23-20Initiated Cantor Fitzgerald Overweight $24
Sep-23-20Upgrade H.C. Wainwright Neutral → Buy $20
May-18-20Downgrade H.C. Wainwright Buy → Neutral
May-15-20Downgrade Maxim Group Buy → Hold
Jan-10-20Reiterated Maxim Group Buy $3 → $12
Feb-28-24 09:14AM
Feb-23-24 11:30AM
Feb-08-24 10:39AM
Feb-07-24 09:08AM
Feb-05-24 02:35PM
11:46AM Loading…
Jan-05-24 11:46AM
09:12AM
Dec-26-23 05:06AM
Dec-15-23 06:06PM
Dec-13-23 11:10AM
Dec-12-23 02:02PM
09:13AM
Dec-08-23 07:31PM
Dec-07-23 04:01PM
Nov-14-23 09:53PM
09:39AM Loading…
Nov-07-23 09:39AM
09:01AM
Nov-06-23 09:15AM
Oct-31-23 08:15AM
Oct-25-23 09:15AM
Oct-19-23 09:59AM
Oct-16-23 07:01PM
05:26PM
Oct-13-23 03:29PM
03:29PM
12:45PM
11:21AM
Oct-12-23 11:43PM
Oct-06-23 03:13PM
Oct-05-23 09:15AM
09:00AM Loading…
Oct-02-23 09:00AM
Sep-18-23 09:15AM
Sep-14-23 06:30AM
Sep-13-23 05:20PM
Sep-11-23 09:10AM
Sep-06-23 09:15AM
Aug-29-23 07:30AM
Aug-03-23 09:07AM
Jul-29-23 11:30AM
Jul-13-23 07:31AM
Jul-05-23 11:44AM
09:15AM
Jun-27-23 09:15AM
Jun-12-23 10:19AM
09:15AM
Jun-01-23 09:15AM
May-30-23 12:06PM
May-23-23 09:50AM
May-12-23 04:39PM
May-11-23 02:40PM
09:15AM
May-08-23 09:15AM
May-01-23 09:00AM
Apr-26-23 09:12AM
Mar-09-23 09:45AM
Mar-04-23 07:20AM
Mar-03-23 07:07AM
Feb-28-23 09:15AM
Feb-24-23 01:29PM
Feb-08-23 09:15AM
Feb-01-23 08:55AM
Jan-25-23 08:27PM
Jan-24-23 04:06PM
12:22PM
09:15AM
Jan-18-23 10:35AM
Jan-12-23 09:40AM
Jan-03-23 09:16AM
Dec-20-22 09:15AM
Dec-06-22 09:15AM
Nov-22-22 12:30PM
Nov-18-22 01:30PM
Nov-16-22 10:43AM
Nov-15-22 10:00AM
Nov-14-22 03:54PM
Nov-07-22 09:00AM
06:15AM
Nov-04-22 10:49AM
Nov-03-22 09:15AM
Nov-01-22 02:21PM
Oct-31-22 05:50PM
06:15AM
Oct-27-22 09:15AM
Oct-25-22 05:50PM
Oct-17-22 05:50PM
Oct-13-22 09:15AM
Oct-11-22 06:00PM
06:00AM
Oct-05-22 06:15AM
Sep-30-22 10:35AM
Sep-29-22 06:15PM
Sep-27-22 01:11PM
Sep-23-22 04:11PM
01:43PM
09:19AM
Sep-16-22 06:15PM
Sep-09-22 12:08PM
Sep-08-22 09:15AM
Sep-05-22 08:01PM
Aug-18-22 01:06PM
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBERTSON SANFORDDirectorAug 23Buy17.4530,000523,500886,851Aug 24 04:06 PM
Barry RichardDirectorAug 22Buy16.6516,571275,907293,477Aug 23 04:58 PM
Barry RichardDirectorAug 21Buy16.801,90632,021276,906Aug 23 04:58 PM
SCANNON PATRICK J MD PHDDirectorJun 12Option Exercise0.951,0009501,000Jun 12 04:53 PM
BARBIER REMIPresident and CEOMay 24Option Exercise16.8771,4281,204,990782,002May 25 05:11 PM
BARBIER REMIPresident and CEOMay 24Option Exercise16.8714,285240,988390,397May 25 05:11 PM
ROBERTSON SANFORDDirectorMay 10Option Exercise17.799,284165,170856,851May 10 04:08 PM
GUSSIN ROBERT ZDirectorMay 01Option Exercise17.799,284165,17017,694May 02 04:04 PM
O DONNELL MICHAEL JDirectorMar 07Option Exercise18.137,142129,48412,012Mar 08 04:12 PM
Barry RichardDirectorMar 07Buy25.7677,2761,990,630275,000Mar 08 04:07 PM
Barry RichardDirectorMar 06Buy26.1311,565302,193197,724Mar 08 04:07 PM